Polls over, states seek relaxation in code of conduct for smooth administration

State administration has to take a slew of policy decisions and expedite project implementation …read more

Source: India – Business Standard

    

ICAI to issue norms on fraud reporting by auditors

ICAI will also soon come out with a guidance document for its members on detecting and reporting fraud …read more

Source: India – Business Standard

    

FIPB defers call on HDFC Bank’s plan to raise FII limit

The bank had proposed to increase its FII limit to 67.55% from about 51% at present …read more

Source: India – Business Standard

    

‘Broad areas of South Asia could see below-normal rains’

A few IMD weather forecasters were also part of the deliberations …read more

Source: India – Business Standard

    

81 power projects take off in 10 months

The Project Monitoring Group is now looking to facilitate investments in 212 projects worth Rs 10.57 lakh cr …read more

Source: India – Business Standard

    

Minister Jason Kenney will make an important announcement to help Alberta residents get jobs.

Jason Kenney, Minister of Employment and Social Development, and the Honourable Manmeet Bhullar, Alberta Minister of Human Services, will make an important announcement that will help Alberta residents get jobs. …read more

Source: Government of Canada

    

Omnicare Reports First-Quarter 2014 Financial Results

Cincinnati, Apr 24, 2014 – (ACN Newswire) – Omnicare, Inc. (NYSE:OCR) reported today financial results for its first-quarter ended March 31, 2014.

First-Quarter Highlights:

– Net sales increase of 7.7% to $1.6 billion
– Adjusted cash earnings per diluted share from continuing operations 8.3% higher to $0.91; GAAP earnings per diluted share of $0.59
– Adjusted EBITDA from continuing operations up 10.4% to $178 million
– Cash flows from continuing operations increase of 61% to $172 million

“We are pleased with our first quarter results from continuing operations with net sales up nearly 8% and adjusted EBITDA from continuing operations marking another double-digit increase,” said John Workman, Omnicare’s Chief Executive Officer. “Our strong first-quarter results demonstrate our sound financial footing and the progress we have made as an organization. It also sets the foundation for our previously announced leadership transition whereupon Nitin Sahney will become our new CEO upon my retirement.”

First-Quarter Results

Financial results from continuing operations for the quarter ended March 31, 2014, as compared with the same prior-year period, were as follows:

– Net sales were $1,571 million versus $1,459 million
– Gross profit was $358 million as compared with $350 million
– GAAP earnings per share was $0.59 versus $0.45
– Adjusted cash …read more

Source: ACN Newswire

    

Cytokinetics to Host Investor Breakfast and Webcast Following Presentation of Results from BENEFIT-ALS

South San Francisco, CA, Apr 24, 2014 – (ACN Newswire) – Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that it plans to host an Investor Breakfast and Webcast on the morning following the presentation of the results from the BENEFIT-ALS trial at the 66th Annual Meeting of the American Academy of Neurology. The Cytokinetics sponsored event will be held on Wednesday, April 30th from 7:00 AM – 9:00 AM Eastern Time in the Grand Ballroom of the Ritz Carlton Hotel, Philadelphia, PA. The formal program and webcast will begin at 7:30 AM Eastern Time.

Cytokinetics will be represented by Robert I. Blum, President and Chief Executive Officer; Dr. Andrew A. Wolff, Senior Vice President of Clinical Research and Development and Chief Medical Officer; Dr. Fady I. Malik, Senior Vice President, Research and Early Development; and Dr. Jinsy Andrews, Director of Clinical Research and Medical Monitor of BENEFIT-ALS. Also participating will be Dr. Jeremy M. Shefner, Professor and Chair, Department of Neurology at the Upstate Medical University, State University of New York and Principal Investigator of BENEFIT-ALS; Dr. Robert G. Miller, Clinical Professor of Neurology and Neurological Sciences at Stanford University, and Director of the Forbes Norris ALS Research Center at the …read more

Source: ACN Newswire